FDA Inspection 833767 — Steven Rohrbeck
The FDA completed an inspection of Steven Rohrbeck on May 6, 2013 in High Point, NC. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- May 6, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- High Point, NC (United States)
Additional Details
Clinical Investigator (CI)